Diet boosts Crohn's drug in kids: new study hopes to cut meds
NCT ID NCT07314606
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a special diet (Crohn's Disease Exclusion Diet) to the standard drug infliximab helps children with Crohn's disease feel better and stay in remission longer. About 140 children starting infliximab will be randomly assigned to receive the diet plus drug or drug alone. The goal is to improve treatment response and reduce long-term medication needs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of British Columbia
RECRUITINGVancouver, British Columbia, V5Z 4H4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tree mushroom drink calm inflammatory bowel disease?
- Sleep hormone melatonin put to the test for IBD patients with poor sleep
- Which diet do IBD patients prefer? intermittent fasting, mediterranean, or low FODMAP?
- Can better detection of precancerous lesions in IBD prevent colorectal cancer?
- Could a postbiotic soothe irritable bowel syndrome?
- Which biologic best stops Crohn's from coming back after surgery?